Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TUBE1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA556916
Description
Immunogen sequence: NMDLNEISMN LVPFPQLHYL VSSLTPLYTL TDVNIPPRRL DQMFSDAFSK DHQLLRADPK HSLYLACALM VRGNVQISDL RRNIERLKPS LQFVS Highest antigen sequence identity to the following orthologs: Mouse - 93%, Rat - 92%.
Microtubules constitute one of the major components of eukaryotic cells cytoskeleton and are involved in many essential processes, including cell division, ciliary and flagellar motility and intracellular transport. Microtubules of the eukaryotic cytoskeleton are composed of a heterodimer of α- and β-tubulin. In addition to α- and β-tubulin, several other tubulins have been identified, bringing the number of distinct tubulin classes to seven. Most of these tubulins have distinct subcellular localization and an emerging, diverse set of functions.
Specifications
| TUBE1 | |
| Polyclonal | |
| Unconjugated | |
| TUBE1 | |
| 2310061K05Rik; AI551343; dJ142L7.2; epsilon-tubulin; epsilon-tubulin 1; FLJ22589; FLJ44203; RP1-142L7.1; TUBE; Tube1; Tubulin; tubulin epsilon 1; tubulin epsilon chain; tubulin, epsilon 1 | |
| Rabbit | |
| Antigen Affinity Chromatography | |
| RUO | |
| 51175 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.05 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q9UJT0 | |
| TUBE1 | |
| Recombinant protein corresponding to Human TUBE1. Recombinant protein control fragment (Product #RP-94620). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction